Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
SC

Shawn Cabral — 8 Patents

Pfizer: 8 patents #652 of 5,153Top 15%
Groton, CT: #27 of 198 inventorsTop 15%
Connecticut: #5,708 of 34,797 inventorsTop 20%
Overall (All Time): #600,572 of 4,157,543Top 15%
8 Patents All Time
Shawn Cabral has been granted 8 US patents while listed as an inventor at Pfizer. The first was granted in 2016 and the most recent in October 2024. Shawn Cabral ranks #600,572 of 4,157,543 US inventors in our database (top 14.4%). Patent records list Shawn Cabral in Groton, CT, US.

Patents per Year

Patents granted per year, 2016 to 2024Bar chart with a peak of 2 patents in 2016.peak 22016: 2 patents20162018: 1 patents20182021: 2 patents20212023: 1 patents20232024: 2 patents2024

Issued Patents All Time

Showing 1–8 of 8 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12103921 Chemical compounds Ariamala Gopalsamy, Agustin Casimiro Garcia, Ming Zhu Chen, Chulho Choi, Robert L. Dow +10 more 2024-10-01 $338,444,000
11866425 Diacylglycerol acyl transferase 2 inhibitors Markus Boehm, Matthew S. Dowling, Kentaro Futatsugi, Kim Huard, Esther Cheng Yin Lee +4 more 2024-01-09 $444,468,000
11702405 Chemical compounds Ariamala Gopalsamy, Agustin Casimiro-Garcia, Ming Zhu Chen, Chulho Choi, Robert L. Dow +10 more 2023-07-18 $390,606,000
11034678 Diacylglycerol acyl transferase 2 inhibitors Markus Boehm, Matthew S. Dowling, Kentaro Futatsugi, Kim Huard, Esther Cheng Yin Lee +4 more 2021-06-15 $1,312,533,000
11014908 Chemical compounds Ariamala Gopalsamy, Arjun Venkat Narayanan, Agustin Casimiro-Garcia, Chulho Choi, David Hepworth +10 more 2021-05-25 $425,301,000
10071992 Diacylglycerol acyl transferase 2 inhibitors Markus Boehm, Matthew S. Dowling, Kentaro Futatsugi, Kim Huard, Esther Cheng Yin Lee +4 more 2018-09-11 $275,302,000
9440949 Diacylglycerol acyltransferase 2 inhibitors Kentaro Futatsugi, David Hepworth, Kim Huard, Daniel Wei-Shung Kung, Suvi Tuula Marjukka Orr +1 more 2016-09-13 $277,429,000
9296745 Diacylglycerol acyltransferase 2 inhibitors Kay Ahn, Markus Boehm, Philip A. Carpino, Kentaro Futatsugi, David Hepworth +3 more 2016-03-29 $310,571,000